Metronet Hires Two Industry Leaders
Senior Leaders to Bolster Company’s Technology and Commercial Sales Groups EVANSVILLE, Ind.–(BUSINESS WIRE)–Metronet today announced the appointment... Read more.
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
SAN ANTONIO–(BUSINESS WIRE)–#BIAF—bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on commercializing noninvasive... Read more.
Ayodele Okeowo, Senior Commerce Department and CHIPS Program Office Official, Joins Tusk Strategies to Further Grow Federal Capabilities and CHIPS Act Practice
WASHINGTON–(BUSINESS WIRE)–Building off a decade-plus of guiding companies and organizations through major regulatory and public affairs challenges,... Read more.
Global Transdermal Medical Patch Market Analysis and Forecast to 2029: Growing Number of Smokers, Rising use for Insulin Delivery and Upswing in Hormonal Deficiencies Drives Demand – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Transdermal Medical Patch Market: Analysis By Type, By Application, By Distribution Channel, By Region Size... Read more.
LTC Declares Its Monthly Common Stock Cash Dividend for the Second Quarter of 2024
WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties Inc. (NYSE: LTC) (“LTC” or the “Company”) announced today that it had declared a monthly... Read more.
Ventas Issues Business Update
CHICAGO–(BUSINESS WIRE)–In conjunction with upcoming investor meetings, Ventas, Inc. (NYSE: VTR) (the “Company”) has issued a business update which... Read more.
Acrisure Rolls Out Midwest Region Serving America’s Heartland
MILWAUKEE–(BUSINESS WIRE)–Acrisure today announced the formation of its Midwest Region which comprises businesses in Illinois, Iowa, Kansas, Minnesota,... Read more.
Calix to Post First Quarter 2024 Results on April 22, 2024
SAN JOSE, Calif.–(BUSINESS WIRE)–Calix, Inc. (NYSE:CALX) today announced that on Monday, April 22, 2024, after market close, the company will post on... Read more.
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
Revenues for H2 2023 were affected by damages caused by the terrorist attack on October 7, 2023 and the war in Gaza. However, InterCure it is entitled to full compensation... Read more.
Oragenics, Inc. Files 10K and Provides Company Update
SARASOTA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (the “Company”) (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals... Read more.